Covid-19 Igg/igm Rapid Test

Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following: General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients. Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels. Epidemiological COVID-19 surveys at national and district levels for research purposes. Airport screening for arriving /departing passengers to control the pandemic in the aviation industry. Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures. Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies. Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.

COVID-19 IgG/IgM Rapid Test Kit (Colloidal Gold) The accuracy of the rapid test is 93% for IgM detection and 98% for IgG detection, compared to the RT-PCR Tests done at individual labs in The Netherlands. Pricing clears and depends on volumes naturally. Please ask the exact quote with the volume requested information. CE and FDA EUA approved Made in USA, Germany, Canada

Till now we already exported 20 million tests and we can promise you very high quality. 25 tests/box, CE Mark and ISO, Clinical report, Certificate of analysis (COA) available Clinical specify >98.89% Accuracy: 93.41% Specimen: whole blood/serum, 10 minutes to get results

Rapid 2019-nCoV IgG/IgM Combo Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. Rapid 2019-nCoV IgG/IgM Combo Test Card is a supplement detection for COVID-19 suspected infected patients besides nucleic acid test, which could greatly raise the accuracy of the detection for COVID-19. 25 tests/box, CE Mark and ISO, Clinical report, Certificate of analysis (COA) Clinical specify >98.89% Accuracy: 93.41% Specimen: whole blood/serum, 10 minutes to get results

Name Testing kit for New coronavirus (2019-nCOV) IgG/IgM antibody Rapid Test WB/S/P Specifications 25 tests Introduce This kit uses the colloidal gold immunochromatographic principle to qualitatively detect novel coronavirus igg/igm antibodies in human serum, plasma, or whole blood. the sample to be tested was added to the sample hole of the test paper, and then added 2 drops of sample diluent. the igg/igm antibody in the sample combined with the recombinant new coronavirus antigen labeled with the colloidal gold on the binding pad formed complex. under the action of chromatography, it diffused forward along the nitrocellulose membrane (nc membrane). the nitrocellulose membrane was fixed with two detection lines (g line, m line) and one quality control line (c line). the g line was fixed with anti-human igg antibody for the detection of new coronavirus igg antibody; the m line was fixed with anti-human igm antibody for the detection of new coronavirus igm antibody; and the c line had quality control for the detection of the new coronavirus ig antibody. If the sample contains a new coronavirus IgG antibody, then the antibody binds to the recombinant new coronavirus antigen labeled with colloidal gold, diffuses forward, and then binds to the anti-human IgG antibody fixed on the NC membrane detection line (G line). if the sample contains a novel coronavirus igm antibody, then the antibody binds to the recombinant new coronavirus antigen labeled with colloidal gold, diffuses forward, and then binds to the anti-human igm antibody fixed on the nc membrane detection line (m line). The darker the color of the colloidal gold accumulated on the detection line, the higher the concentration of the new coronavirus antibody in the sample. To monitor the effectiveness of the test card, set up a quality control line (line C), whether there is a detection line (line T), quality control line (line C) should be color, otherwise the test results are judged invalid. Storage Stored at 4 to 30c and valid for 18 months. After the aluminum foil bag is unsealed, please use it as soon as possible. Sample 1. It is suitable for human serum, plasma and whole blood samples. 2. The samples should be used as soon as possible; if they cannot be used immediately, the serum / plasma samples should be kept at 2-8C for 5 days and -20C for long-term preservation; the whole blood samples should be placed at 2-8C to avoid hemolysis; 3.The sample contains a large amount of lipids, hemolysis or turbidity, do not use, so as not to affect the judgment of the results.

I am the manufacturer of COVID-19 RAPID TEST in China. The ACtest COVID-19 IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG and IgM anti-nCoV-19 virus in human whole blood, serum or plasma. It is intended to be used by the professionals as a screening test and as an aid in the diagnosis of infection with nCoV-19 viruses. The product has obtained the CE certification and is on the list of government export permits. And has been exported to Thailand, the Philippines, Germany, Italy, Ecuador, South Africa and other countries.

COVID-19 (2019-nCoV) Coronavirus IgG/IgM Rapid Test Kit Principle: based on Colloidal Gold Method, to detect COVID-19 IgG/IgM Antibody in serum, plasma, whole blood qualitatively. Easy to operate, results can be obtained in 15 minutes. Component: 25 tests cassttes/ 25 dropper/ 25 tubes of dilution buffer/25 Alcohol pad/ 25 Lancet/ 1 manual Certificate: CE, ISO13485, ISO9001

In the past two months, China was infected by the COVID-19( Noval Coronavirus), in order to diagnose the diseases earlier, Encode team work hard and finally develop the COVID-19 IgM/IgG rapid test kit, which clinical positive detection rate is over 90%.

The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Gives Positive or Negative Result for COVID-19 virus Read Results in 15 Minutes 24 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert